Lilly Insulin Glargine Versus Lantus(®) in Insulin-Naïve and Insulin-Treated Adults with Type 2 Diabetes: A Randomized, Controlled Trial (ELEMENT 5)

INTRODUCTION: This study compared the efficacy and safety of similar U-100 insulin glargine products, namely, Lilly insulin glargine (LY IGlar; Basaglar(®)) and the reference insulin glargine product (IGlar; Lantus(®)), used once daily in combination with oral antihyperglycemic medications (OAMs) in...

Descripción completa

Detalles Bibliográficos
Autores principales: Pollom, Robyn K., Ilag, Liza L., Lacaya, Lyndon B., Morwick, Tina M., Ortiz Carrasquillo, Ramón
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349279/
https://www.ncbi.nlm.nih.gov/pubmed/30604091
http://dx.doi.org/10.1007/s13300-018-0549-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349279/
https://www.ncbi.nlm.nih.gov/pubmed/30604091
http://dx.doi.org/10.1007/s13300-018-0549-3

Ejemplares similares